Prioritising Lung Health: How FeNO can help to tackle Lung Conditions, the UK’s 3rd Largest Threat

FHS
October 4, 2023
11:15 am

A new report from PwC commissioned by Asthma+Lung UK has highlighted the alarming crisis surrounding Lung Health in the UK.

The FDA almost never pulls fully-approved drugs. Amylyx’s ALS treatment might be the exception

Barring safety issues, the FDA almost never pulls fully-approved drugs from the market. But given the magnitude of the failure with Amylyx’s Phase III data

March 9, 2024

Ascend Wellness Q2 Revenue Increases to Record $123 Million

AWH ANNOUNCES Q2 2023 FINANCIAL RESULTS Reported Record Quarterly Revenue Achieved $123.0M Net Revenue in Q2 2023, a 26.1% Increase Year-Over-Year and 7.7% Increase Quarter-Over-Quarter

August 9, 2023

A bad day to be a salmon

It’s my last week here at Morning Rounds, but I have some exciting news just for you: Starting next February, you’ll be able to catch

December 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.